Skip to main content
. 2023 Dec 8;109(5):1222–1230. doi: 10.1210/clinem/dgad722

Table 2.

Comparison of clinicopathological characteristics of follicular thyroid cancer in various clinical settings

Variable Level Comparison 1 Comparison 2 Comparison 3
TC-BC TCnoBC P TC-1st TCnoBC P BC-1st TCnoBC P
n 604 3020 314 1570 290 1450
Age, y (median [IQR]) 61.00
(50.00-71.00)
61.00
(50.00-70.00)
.743 55.00
(45.00-66.00)
55.00
(45.00-66.00)
.848 67.00
(57.00-74.00)
66.00
(57.00-74.00)
.764
Race (%) White 490 (81.1) 2362 (78.2) .267 250 (79.6) 1217 (77.5) .7 240 (82.8) 1157 (79.8) .4801
Black 55 (9.1) 328 (10.9) 29 (9.2) 165 (10.5) 26 (9.0) 144 (9.9)
Other 59 (9.7) 330 (10.9) 35 (11.1) 188 (11.9) 24 (8.2) 149 (10.3)
Pathological subtype (%) FA 309 (51.2) 1545 (51.2) .6 176 (56.1) 876 (55.8) .169 133 (45.9) 678 (46.8) .94
OX 191 (31.6) 977 (32.4) 86 (27.4) 473 (30.1) 105 (36.2) 509 (35.1)
FAMI 70 (11.6) 334 (11.1) 28 (8.9) 124 (7.9) 42 (14.5) 204 (14.1)
FAT 10 (1.7) 29 (1.0) 9 (2.9) 18 (1.1) 1 (0.3) 11 (0.8)
FAWD 24 (4.0) 135 (4.5) 15 (4.8) 79 (5.0) 9 (3.1) 48 (3.3)
Stage (%) Localized 437 (72.4) 2083 (69.0) .04c 217 (69.1) 1000 (63.7) .043c 220 (75.9) 1073 (74.0) .398
Regional 130 (21.5) 658 (21.8) 83 (26.4) 441 (28.1) 47 (16.2) 224 (15.4)
Distant 37 (6.1) 279 (9.2) 14 (4.5) 129 (8.2) 23 (7.9) 153 (10.6)
Tumor size, cm (%) <1 38 (6.3) 151 (5.0) <.001a 22 (7.0) 87 (5.5) .087d 16 (5.5) 62 (4.3) <.001a
1-2 178 (29.5) 674 (22.3) 90 (28.7) 370 (23.6) 88 (30.3) 294 (20.3)
2-4 244 (40.4) 1353 (44.8) 123 (39.2) 724 (46.1) 121 (41.7) 634 (43.7)
>4 144 (23.8) 842 (27.9) 79 (25.2) 389 (24.8) 65 (22.4) 460 (31.7)
Extension (%) Localized 515 (85.3) 2501 (82.8) .036c 278 (88.5) 1319 (84.0) .024c 237 (81.7) 1181 (81.4) .626
Beyond capsule 73 (12.1) 366 (12.1) 31 (9.9) 175 (11.1) 42 (14.5) 196 (13.5)
Further 16 (2.6) 153 (5.1) 5 (1.6) 76 (4.8) 11 (3.8) 73 (5.0)
LN Met (%) Yes 32 (5.3) 209 (6.9) .17 15 (4.8) 109 (6.9) .198 17 (5.9) 106 (7.3) .451
No 572 (94.7) 2811 (93.1) 299 (95.2) 1461 (93.1) 273 (94.1) 1344 (92.7)
Dis Met (%) Yes 37 (6.1) 276 (9.1) .02c 14 (4.5) 127 (8.1) .034c 23 (7.9) 152 (10.5) .226
No 567 (93.9) 2744 (90.9) 300 (95.5) 1443 (91.9) 267 (92.1) 1298 (89.5)
Multifocal (%) Yes 66 (18.4) 287 (16.0) .534 24 (18.9) 97 (6.2) .595 42 (14.5) 190 (13.1) .813
No 292 (81.6) 1503 (84.0) 103 (81.1) 538 (34.3) 189 (65.2) 965 (66.6)
TC-specific mortality (%) Yes 35 (5.8) 255 (8.4) .035c 13 (4.1) 130 (8.3) .016c 22 (7.6) 122 (8.4) .726
No 569 (94.2) 2765 (91.6) 301 (95.9) 1440 (91.7) 268 (92.4) 1328 (91.6)
Marital status (%) Married 352 (58.3) 1759 (58.2) ≥.999 191 (60.8) 982 (62.5) .61 161 (55.5) 789 (54.4) .78
Unmarried 252 (41.7) 1261 (41.8) 123 (39.2) 588 (37.5) 129 (44.5) 661 (45.6)
Insurance (%) Yes 269 (44.5) 1332 (44.1) 72 (22.9) 360 (22.9) 197 (67.9) 974 (67.2)
No 3 (0.5) 28 (0.9) .574 2 (0.6) 10 (0.6) ≥.999 1 (0.3) 16 (1.1) .486
Not 2007+ 332 (55.0) 1660 (55.0) 240 (76.4) 1200 (76.4) 92 (31.7) 460 (31.7)
Education (median [IQR]) 83.55
(79.18-88.68)
84.36
(79.46-88.42)
.217 83.55
(78.36-86.43)
83.55
(79.46-87.52)
.032c 85.40
(79.21-89.65)
86.00
(80.27-89.27)
.746
Income (median [IQR]) 5525.00
(4227.00-6102.00)
5548.00
(4244.00-6191.75)
.315 5087.00
(4219.00-5683.98)
5316.00
(4219.00-5829.00)
.248 5607.50
(4555.25-6387.50)
5620.00
(4586.25-6799.50)
.363
Unemployment (median [IQR]) 7.75 (5.69-8.70) 7.68 (5.59-8.70) .972 7.53 (5.30-8.23) 7.39 (5.25-8.23) .834 7.80 (5.94-9.60) 7.80 (6.03-9.53) .875

Abbreviations: BC, breast cancer; BC-1st, TC patients diagnosed after BC; Dis, distant; FA, follicular adenocarcinoma, NOS; FAT, FA trabecular; FAWD, FA well differentiated; IQR, interquartile range; LN, lymph node; Met, metastases; OX, oxyphilic adenocarcinoma; TC, thyroid cancer; TC-1st, TC patients diagnosed before BC; TCnoBC, TC patients without history of BC.

a P less than .001; bP less than .01; cP less than .05; dP less than .1.